nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Editorial Board
|
|
|
|
4 |
4 |
p. ii |
artikel |
2 |
Efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma treatment in patients aged ≥80 years
|
Tsuchiya, Kyohei |
|
|
4 |
4 |
p. 206-211 |
artikel |
3 |
Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
|
Shih, Tsung-Chieh |
|
|
4 |
4 |
p. 168-172 |
artikel |
4 |
Golgi protein 73, hepatocellular carcinoma and other types of cancers
|
Wang, Yanan |
|
|
4 |
4 |
p. 161-167 |
artikel |
5 |
Hepatocellular carcinoma clinical update: Current standards and therapeutic strategies
|
Colquhoun, Steven D. |
|
|
4 |
4 |
p. 180-190 |
artikel |
6 |
Hepatocellular carcinoma diagnosis and treatment: An overview
|
Colquhoun, Steven D. |
|
|
4 |
4 |
p. 159-160 |
artikel |
7 |
Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiome
|
Vaziri, Farzam |
|
|
4 |
4 |
p. 191-198 |
artikel |
8 |
Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
|
Setayesh, Tahereh |
|
|
4 |
4 |
p. 173-179 |
artikel |
9 |
Relationship between outcomes and relative dose intensity of lenvatinib treatment in patients with advanced hepatocellular carcinoma
|
Ohki, Takamasa |
|
|
4 |
4 |
p. 199-205 |
artikel |
10 |
Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization
|
Xia Qian, |
|
|
4 |
4 |
p. 212-217 |
artikel |